Advertisement
(Logo: http://www.newscom.com/cgi-bin/prnh/20090107/CLW051LOGO )
"We are very pleased with the user registration growth of BiomedExperts aswell as the accolades that we are receiving from the industry," stated BillKirkland, CEO of Collexis Holdings, Inc. "As our user registration base growsalong with our page views, BiomedExperts is poised to become the industrystandard for life science researchers. We are looking forward to the futurereleases of BiomedExperts and the launch of new portals across the otherscientific disciplines and industries."
Advertisement
Research and advisory firm Outsell, Inc. selected BiomedExperts as one ofthe top 10 social communities to watch in 2009, in its report "Social Media inSTM Part 1: Social Networking"(http://www.outsellinc.com/store/products/792?refid=prcol792). A recentElsevier study found after only seven months post launch, BiomedExperts wasthe second most frequently used life science social network behind Nature butahead of Facebook, MySpace and LinkedIn. Also the launch announcement ofBiomedExperts was the #1 headline on the eHealthNews.EU news portal for 2008.
Pre-populated with over 1.8 million Pub-Med-based expert profiles,BiomedExperts allows scientists and researchers to directly connect with andexplore their own professional contacts, grow their networks and identifyresearchers with the expertise needed for future collaborations. Throughuser-friendly search interfaces, potential research collaborators can sharedata and collaborate with professionals from more than 1,800 organizations andinstitutions from 137 countries, totaling more than 21 million connectionsmade through the site.
About Collexis Holdings, Inc.
Collexis Holdings, Inc., a leading developer of semantic search andknowledge discovery software is headquartered in Columbia, South Carolina(USA) with operations in Cincinnati, Ohio and Cologne, Germany. Collexis nowoffers the world's first pre-populated scientific social network for lifescience researchers, http://www.biomedexperts.com . Collexis' proprietarytechnology builds conceptual profiles of text, called Fingerprints, fromdocuments, Websites, emails and other digitized content and matches them witha comprehensive list of pre-defined "fingerprinted" concepts to make researchresults more relevant and efficient. This matching of concepts eliminates theambiguity and lack of priority associated with word searches. The results areoften described as "finding needles in many haystacks." Through this novelapproach, Collexis can build unique applications to search, index andaggregate information as well as prioritize, trend and predict data based onsources in multiple industries without the limitations of language or dialect.Collexis' current clients in the public, private and academic sectors includethe Mayo Clinic; Johns Hopkins University; Dana-Farber Cancer Institute, theUniversity of California, San Francisco; the University of South Carolina;Erasmus University Library; Bristol-Myers Squibb; Lockheed Martin; the WorldHealth Organization; Wellcome Trust; the National Institutes of Health; andthe U.S. Department of Defense. Shares of Collexis common stock are tradedunder the symbol CLXS on the OTC Bulletin Board (OTC BB). For moreinformation, visit http://www.collexis.com .
Forward-Looking Statements
Some of the statements made in this press release may constitute forward-looking statements within the meaning of the Private Securities LitigationReform Act of 1995. These forward-looking statements are based on management'scurrent expectations and include known and unknown risks, uncertainties andother factors, many of which the company is unable to predict or control, thatmay cause the company's actual results or performance to differ materiallyfrom any future results or performance expressed or implied by such forward-looking statements. These statements involve risks and uncertainties,including risks and uncertainties associated with BiomedExperts.com. Theserisks and uncertainties are in addition to other factors detailed from time totime in the company's filings with the SEC, including the section entitled"Risk Factors" in its transition report on Form 10-KSB for the period endedJune 30, 2008. The company cautions investors that any forward-lookingstatements made by the company are not necessarily indicative of futureperformance. The company is not responsible for updating the informationcontained in this press release beyond the published date, or for changes madeto this document by wire services or Internet services.
SOURCE Collexis Holdings Inc.
